Annual Operating Profit
-$38.96 M
-$10.15 M-35.22%
31 December 2023
Summary:
Cellectar Biosciences annual operaing income is currently -$38.96 million, with the most recent change of -$10.15 million (-35.22%) on 31 December 2023. During the last 3 years, it has fallen by -$23.67 million (-154.81%). CLRB annual operating profit is now -1418.10% below its all-time high of -$2.57 million, reached on 31 December 2005.CLRB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$13.33 M
+$376.00 K+2.74%
30 September 2024
Summary:
Cellectar Biosciences quarterly operating income is currently -$13.33 million, with the most recent change of +$376.00 thousand (+2.74%) on 30 September 2024. Over the past year, it has dropped by -$3.91 million (-41.58%). CLRB quarterly operating profit is now -3674.48% below its all-time high of -$353.10 thousand, reached on 31 March 2005.CLRB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$51.58 M
-$3.91 M-8.21%
30 September 2024
Summary:
Cellectar Biosciences TTM operating income is currently -$51.58 million, with the most recent change of -$3.91 million (-8.21%) on 30 September 2024. Over the past year, it has dropped by -$17.75 million (-52.45%). CLRB TTM operating profit is now -14507.99% below its all-time high of -$353.10 thousand, reached on 31 March 2005.CLRB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.2% | -41.6% | -52.5% |
| 3 y3 years | -154.8% | -129.0% | -134.4% |
| 5 y5 years | -234.3% | -236.2% | -296.7% |
CLRB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -154.8% | at low | -129.0% | +2.7% | -134.4% | at low |
| 5 y | 5 years | -234.3% | at low | -293.8% | +2.7% | -296.7% | at low |
| alltime | all time | -1418.1% | at low | -3674.5% | +2.7% | <-9999.0% | at low |
Cellectar Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.33 M(-2.7%) | -$51.58 M(+8.2%) |
| June 2024 | - | -$13.70 M(+14.2%) | -$47.67 M(+12.8%) |
| Mar 2024 | - | -$12.00 M(-4.4%) | -$42.26 M(+8.5%) |
| Dec 2023 | -$38.96 M(+35.2%) | -$12.55 M(+33.3%) | -$38.96 M(+15.1%) |
| Sept 2023 | - | -$9.41 M(+13.5%) | -$33.84 M(+5.0%) |
| June 2023 | - | -$8.29 M(-4.7%) | -$32.24 M(+2.7%) |
| Mar 2023 | - | -$8.71 M(+17.3%) | -$31.38 M(+8.9%) |
| Dec 2022 | -$28.81 M(+19.4%) | -$7.42 M(-5.0%) | -$28.81 M(+5.5%) |
| Sept 2022 | - | -$7.82 M(+5.1%) | -$27.31 M(+7.9%) |
| June 2022 | - | -$7.44 M(+21.1%) | -$25.32 M(+5.9%) |
| Mar 2022 | - | -$6.14 M(+3.7%) | -$23.91 M(-0.9%) |
| Dec 2021 | -$24.13 M(+57.8%) | -$5.92 M(+1.8%) | -$24.13 M(+9.7%) |
| Sept 2021 | - | -$5.82 M(-3.5%) | -$22.01 M(+9.5%) |
| June 2021 | - | -$6.03 M(-5.2%) | -$20.10 M(+13.6%) |
| Mar 2021 | - | -$6.36 M(+67.4%) | -$17.69 M(+15.7%) |
| Dec 2020 | -$15.29 M(+7.8%) | -$3.80 M(-2.8%) | -$15.29 M(+2.8%) |
| Sept 2020 | - | -$3.91 M(+7.9%) | -$14.88 M(-0.4%) |
| June 2020 | - | -$3.62 M(-8.5%) | -$14.93 M(+2.9%) |
| Mar 2020 | - | -$3.96 M(+17.0%) | -$14.51 M(+2.3%) |
| Dec 2019 | -$14.18 M(+21.6%) | -$3.38 M(-14.6%) | -$14.18 M(+9.0%) |
| Sept 2019 | - | -$3.96 M(+23.9%) | -$13.00 M(+7.2%) |
| June 2019 | - | -$3.20 M(-11.8%) | -$12.13 M(+2.5%) |
| Mar 2019 | - | -$3.63 M(+64.3%) | -$11.83 M(+1.5%) |
| Dec 2018 | -$11.66 M(-14.3%) | -$2.21 M(-28.4%) | -$11.66 M(-13.9%) |
| Sept 2018 | - | -$3.09 M(+6.3%) | -$13.53 M(-2.8%) |
| June 2018 | - | -$2.90 M(-15.9%) | -$13.93 M(-2.2%) |
| Mar 2018 | - | -$3.45 M(-15.5%) | -$14.24 M(+4.7%) |
| Dec 2017 | -$13.60 M(+43.9%) | -$4.09 M(+17.4%) | -$13.60 M(+11.8%) |
| Sept 2017 | - | -$3.48 M(+8.3%) | -$12.16 M(+9.1%) |
| June 2017 | - | -$3.22 M(+14.4%) | -$11.14 M(+8.6%) |
| Mar 2017 | - | -$2.81 M(+6.2%) | -$10.26 M(+8.6%) |
| Dec 2016 | -$9.45 M(+10.5%) | -$2.65 M(+7.3%) | -$9.45 M(+10.3%) |
| Sept 2016 | - | -$2.47 M(+5.8%) | -$8.56 M(+5.7%) |
| June 2016 | - | -$2.33 M(+16.6%) | -$8.10 M(+1.7%) |
| Mar 2016 | - | -$2.00 M(+13.5%) | -$7.97 M(-6.9%) |
| Dec 2015 | -$8.55 M(-11.5%) | -$1.76 M(-11.9%) | -$8.55 M(-5.4%) |
| Sept 2015 | - | -$2.00 M(-9.0%) | -$9.04 M(-2.9%) |
| June 2015 | - | -$2.20 M(-14.9%) | -$9.31 M(-1.5%) |
| Mar 2015 | - | -$2.59 M(+14.8%) | -$9.45 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$9.67 M(-14.5%) | -$2.25 M(-0.9%) | -$9.67 M(-6.8%) |
| Sept 2014 | - | -$2.27 M(-2.9%) | -$10.38 M(-5.8%) |
| June 2014 | - | -$2.34 M(-16.5%) | -$11.01 M(-3.4%) |
| Mar 2014 | - | -$2.80 M(-5.3%) | -$11.39 M(+0.8%) |
| Dec 2013 | -$11.30 M(+29.1%) | -$2.96 M(+1.7%) | -$11.30 M(+7.6%) |
| Sept 2013 | - | -$2.91 M(+6.9%) | -$10.51 M(+8.9%) |
| June 2013 | - | -$2.72 M(+0.4%) | -$9.65 M(+5.6%) |
| Mar 2013 | - | -$2.71 M(+25.4%) | -$9.14 M(+4.4%) |
| Dec 2012 | -$8.75 M(+39.2%) | -$2.16 M(+5.3%) | -$8.75 M(+1.7%) |
| Sept 2012 | - | -$2.05 M(-7.1%) | -$8.61 M(+1.7%) |
| June 2012 | - | -$2.21 M(-4.9%) | -$8.47 M(+5.6%) |
| Mar 2012 | - | -$2.33 M(+15.2%) | -$8.01 M(+27.4%) |
| Dec 2011 | -$6.29 M(+51.9%) | -$2.02 M(+5.6%) | -$6.29 M(+31.5%) |
| Sept 2011 | - | -$1.91 M(+8.7%) | -$4.78 M(+37.5%) |
| June 2011 | - | -$1.76 M(+191.6%) | -$3.48 M(+7.0%) |
| Mar 2011 | - | -$603.10 K(+18.3%) | -$3.25 M(-37.4%) |
| Dec 2010 | -$4.14 M(-59.3%) | -$509.80 K(-16.0%) | -$5.19 M(-37.1%) |
| Sept 2010 | - | -$607.10 K(-60.3%) | -$8.26 M(-17.0%) |
| June 2010 | - | -$1.53 M(-39.9%) | -$9.95 M(-5.1%) |
| Mar 2010 | - | -$2.55 M(-28.8%) | -$10.48 M(+3.1%) |
| Dec 2009 | -$10.17 M(-38.7%) | -$3.58 M(+55.6%) | -$10.17 M(+16.3%) |
| Sept 2009 | - | -$2.30 M(+11.4%) | -$8.74 M(-2.9%) |
| June 2009 | - | -$2.06 M(-7.5%) | -$9.00 M(-22.8%) |
| Mar 2009 | - | -$2.23 M(+3.7%) | -$11.65 M(-29.8%) |
| Dec 2008 | -$16.59 M(-18.2%) | -$2.15 M(-16.0%) | -$16.59 M(-21.5%) |
| Sept 2008 | - | -$2.56 M(-45.8%) | -$21.14 M(-16.2%) |
| June 2008 | - | -$4.72 M(-34.2%) | -$25.22 M(+1.1%) |
| Mar 2008 | - | -$7.17 M(+7.0%) | -$24.94 M(+22.9%) |
| Dec 2007 | -$20.29 M(+127.3%) | -$6.70 M(+0.8%) | -$20.29 M(+23.5%) |
| Sept 2007 | - | -$6.65 M(+49.8%) | -$16.44 M(+28.5%) |
| June 2007 | - | -$4.44 M(+76.3%) | -$12.79 M(+27.7%) |
| Mar 2007 | - | -$2.52 M(-11.4%) | -$10.01 M(+12.1%) |
| Dec 2006 | -$8.93 M(+248.0%) | -$2.84 M(-5.2%) | -$8.93 M(+30.6%) |
| Sept 2006 | - | -$3.00 M(+80.5%) | -$6.84 M(+42.4%) |
| June 2006 | - | -$1.66 M(+15.7%) | -$4.80 M(+31.6%) |
| Mar 2006 | - | -$1.43 M(+92.2%) | -$3.65 M(+42.1%) |
| Dec 2005 | -$2.57 M | -$746.60 K(-22.3%) | -$2.57 M(+41.0%) |
| Sept 2005 | - | -$960.70 K(+89.9%) | -$1.82 M(+111.8%) |
| June 2005 | - | -$506.00 K(+43.3%) | -$859.10 K(+143.3%) |
| Mar 2005 | - | -$353.10 K | -$353.10 K |
FAQ
- What is Cellectar Biosciences annual operaing income?
- What is the all time high annual operating profit for Cellectar Biosciences?
- What is Cellectar Biosciences annual operating profit year-on-year change?
- What is Cellectar Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly operating profit year-on-year change?
- What is Cellectar Biosciences TTM operating income?
- What is the all time high TTM operating profit for Cellectar Biosciences?
- What is Cellectar Biosciences TTM operating profit year-on-year change?
What is Cellectar Biosciences annual operaing income?
The current annual operating profit of CLRB is -$38.96 M
What is the all time high annual operating profit for Cellectar Biosciences?
Cellectar Biosciences all-time high annual operaing income is -$2.57 M
What is Cellectar Biosciences annual operating profit year-on-year change?
Over the past year, CLRB annual operaing income has changed by -$10.15 M (-35.22%)
What is Cellectar Biosciences quarterly operating income?
The current quarterly operating profit of CLRB is -$13.33 M
What is the all time high quarterly operating profit for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly operating income is -$353.10 K
What is Cellectar Biosciences quarterly operating profit year-on-year change?
Over the past year, CLRB quarterly operating income has changed by -$3.91 M (-41.58%)
What is Cellectar Biosciences TTM operating income?
The current TTM operating profit of CLRB is -$51.58 M
What is the all time high TTM operating profit for Cellectar Biosciences?
Cellectar Biosciences all-time high TTM operating income is -$353.10 K
What is Cellectar Biosciences TTM operating profit year-on-year change?
Over the past year, CLRB TTM operating income has changed by -$17.75 M (-52.45%)